The production process we utilize is proprietary and not available from any other manufacturer. ADT has conducted multiple research projects at MatTek Corporation in Boston Massachusetts. MatTek Corporation is at the forefront of tissue engineering and is a world leader in the production of innovative 3D reconstructed human tissue models.
Based on MatTek research trials and compelling feedback from a 25 patient trial conducted by David A. Silberman M.D., F.A.C.S. (Comparing ADT 4% lidocaine to a compounded BLT cream) ADT has launched our first product ADT Lidocaine 4%.
ADT has performed research on human tissue cultures on a variety of compounds including Lidocaine.
Continued research with several other biologically active compounds is ongoing. We have ongoing projects in the application of topical regenerative therapies and topical cosmetic enhancements. ADT is committed to identifying and developing the molecules/compounds best suited for topical delivery for your patients.
We anticipate the launch of additional Aesthetic and Medical products in 2019.